Please login to the form below
Gene testing
This page shows the latest Gene testing news and features for those working in and with pharma, biotech and healthcare.
AbbVie, Biogen and Pfizer collaboration creates new resource for genetic exome sequence analysis
Working with the Broad Institute, the three companies completed data processing and conducted single variant and gene-based association testing with nearly 4, 000 UK Biobank phenotypes.
Latest news
-
Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
Project will aim to discover and develop a gene therapy for sickle cell disease. ... Current gene therapies in clinical testing for SCD work by taking cells from a patient that are then altered in a laboratory and reintroduced to the patient in a process
-
AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
As part of this first deal, Voyager received $69m upfront to advance gene therapy candidates into phase 1 testing, with AbbVie gaining the option to license one or more for further ... In 2019, French drugmaker Sanofi also scaled back on a gene therapy
-
Astellas makes gene therapy a core focus with $3bn Audentes buy
Meanwhile, Audentes has several other candidates in development, including therapies for Pompe disease, Duchenne muscular dystrophy and myotonic dystrophy that are being prepared for clinical testing. ... It’s not the first gene therapy deal the
-
UniQure gets speedy US review for Huntington’s gene therapy
vector carrying gene designed to reduce levels of an overexpressed protein in Huntington’s disease. ... We are nearing the initiation of a phase 1/2 study of AMT-130, the first one-time administered AAV gene therapy to enter clinical testing for
-
Editas CEO exits the CRISPR firm ahead of first clinical trial
EDIT-101 is also expected to become the of Editas’ gene-editing medicines to start clinical testing, as the company recently got approval for an Investigational New Drug (IND) application for ... EDIT-101 is designed to be delivered directly into the
More from news
Approximately 1 fully matching, plus 15 partially matching documents found.
Latest Intelligence
-
Cell and gene therapy
And even for allogeneic cell therapies and gene therapies, raw materials and analytical testing costs will also need to be reduced” Davies said. ... As a result, Lonza’s efforts to reduce cell and gene therapy production costs involve logistics, said
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Realizing the Potential of Genomics-Driven Precision Medicine
Jennifer Helfer, Senior Director, Patient Advocacy &Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials, how
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- My journey advancing the science in pulmonary hypertension
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
